These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11554011)

  • 21. Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death.
    Yamashita H; Nakamura T; Takahashi T; Nagano Y; Hiji M; Hirabayashi T; Amano T; Yagi T; Sakai N; Kohriyama T; Matsumoto M
    J Neurochem; 2006 Jul; 98(1):45-56. PubMed ID: 16805795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease. Signs of disease in fetal transplants.
    Miller G
    Science; 2008 Apr; 320(5873):167. PubMed ID: 18403684
    [No Abstract]   [Full Text] [Related]  

  • 23. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytosiderosis and iron deposits in ventrolateral nucleus of the thalamus in Parkinson's disease. Clinical and experimental study.
    Asenjo A
    Johns Hopkins Med J; 1968 May; 122(5):284-94. PubMed ID: 4968901
    [No Abstract]   [Full Text] [Related]  

  • 25. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Schlossmacher MG; Cullen V; Müthing J
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719451
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ
    Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
    [No Abstract]   [Full Text] [Related]  

  • 28. Controversy: is Parkinson's disease a single disease entity? Yes.
    Takahashi H; Wakabayashi K
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T
    J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease: piecing together a genetic jigsaw.
    Dekker MC; Bonifati V; van Duijn CM
    Brain; 2003 Aug; 126(Pt 8):1722-33. PubMed ID: 12805097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.
    Liu WG; Lu GQ; Li B; Chen SD
    Parkinsonism Relat Disord; 2007 Mar; 13(2):77-88. PubMed ID: 16963309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic strategies for Parkinson's disease based on data derived from genetic research.
    Riess O; Berg D; Krüger R; Schulz JB
    J Neurol; 2003 Feb; 250 Suppl 1():I3-10. PubMed ID: 12761628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease.
    Lo Bianco C; Déglon N; Pralong W; Aebischer P
    Neurobiol Dis; 2004 Nov; 17(2):283-9. PubMed ID: 15474365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synucleins and their relationship to Parkinson's disease.
    von Bohlen Und Halbach O
    Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
    Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
    Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The last decade in Parkinson's disease research. Basic sciences.
    Przedborski S; Vila M
    Adv Neurol; 2001; 86():177-86. PubMed ID: 11553976
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood vessels change in the mesencephalon of patients with Parkinson's disease.
    Faucheux BA; Bonnet AM; Agid Y; Hirsch EC
    Lancet; 1999 Mar; 353(9157):981-2. PubMed ID: 10459912
    [No Abstract]   [Full Text] [Related]  

  • 38. Parkinson's disease. The apoptosis hypothesis revisited.
    Hartmann A; Hirsch EC
    Adv Neurol; 2001; 86():143-53. PubMed ID: 11553972
    [No Abstract]   [Full Text] [Related]  

  • 39. Natural toxin implicated as triggering Parkinson's disease.
    Pak J Biol Sci; 2011 Feb; 14(3):255. PubMed ID: 21870660
    [No Abstract]   [Full Text] [Related]  

  • 40. 'Like a thief in the night': the selectivity of degeneration in Parkinson's disease.
    Saper CB
    Brain; 1999 Aug; 122 ( Pt 8)():1401-2. PubMed ID: 10430827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.